Itch, proteases and protease-activated receptors

描述（由申请人提供）：瘙痒是皮肤病和内部疾病的主要症状。它可能很难治疗，因为可用的特异性瘙痒抑制剂很少，而且触发瘙痒感的机制尚不清楚。尽管大多数瘙痒实验研究都使用组胺作为瘙痒刺激物，但大多数临床瘙痒病例被认为与组胺无关。引起瘙痒而不释放组胺的天然化合物的发现可能有助于寻找不同于组胺的内源性介质和受体。刺毛黧豆（Mucuna pruriens）植物的针刺刺入表皮时会产生中度至重度瘙痒，且与组胺无关。我们已确定牛中的活性化合物是粘蛋白，一种半胱氨酸蛋白酶。我们还确定 mucunain 是人类蛋白酶激活受体 2 和 4 的配体。我们假设人类半胱氨酸蛋白酶可能与 mucunain 具有同源性，激活这些相同的受体，并作为瘙痒的内源性介质发挥作用。我们提供的数据表明，某些组织蛋白酶，特别是组织蛋白酶 S 就是这种情况。组织蛋白酶与许多过程有关，但以前不被认为是信号分子。目标 1 中提出的实验旨在破译半胱氨酸蛋白酶激活其同源受体的机制。 Aim 2 中提出的用受体敲除小鼠进行的实验将确定这些受体是否确实是组织蛋白酶 S 的伤害性作用所必需的。组织蛋白酶 S 的启动子区域包含 STAT 结合位点，这使我们推测关键的瘙痒相关细胞因子 IL-31 激活其受体，从而诱导组织蛋白酶 S 的表达。这一假设将在目标 3 中得到检验。此处提出的假设和实验将之前与瘙痒和炎症独立相关的三种分子联系在一起：PAR、组织蛋白酶和 IL-31。 公共卫生相关性：瘙痒是皮肤科和许多内部疾病的主要症状，且难以治疗。该项目的目标是检查以前与瘙痒无关的某些蛋白质（称为半胱氨酸蛋白酶）如何打开特定受体并引起瘙痒。该项目的结果可能会导致治疗瘙痒的新药的开发。

DESCRIPTION (provided by applicant): Pruritus is a major symptom of dermatologic and internal conditions. It can be difficult to treat, as few specific inhibitors of itch are available and the mechanism that triggers the sensation of itch is not clear. Although most experimental studies of itch use histamine as the pruritic stimulus, most cases of clinical pruritus are considered to be histamine independent. The discovery of natural compounds that evoke itch without releasing histamine might facilitate the search for endogenous mediators and receptors distinct from histamine. Spicules of the plant Mucuna pruriens (cowhage) when lodged in the epidermis produce moderate to severe itching that is independent of histamine. We have determined that the active compound in cowhage is mucunain, a cysteine protease. We have also determined that mucunain is a ligand for human protease-activated receptors 2 and 4. We hypothesized that human cysteine proteases might share homology with mucunain, activate these same receptors, and function as endogenous mediators of pruritus. We provide data that this is the case with certain cathepsins, notably Cathepsin S. Cathepsins have been implicated in many processes but have not previously been considered signaling molecules. The experiments proposed in Aim 1 are designed to decipher the mechanism by which cysteine proteases activate their cognate receptors. Experiments proposed in Aim 2 with receptor knockout mice will determine if such receptors are indeed necessary for the nociceptive effects of cathepsin S. The promoter region of cathepsin S contains STAT binding sites leading us to hypothesize that the critical pruritus-associated cytokine IL-31 activates its receptor leading to the induction of cathepsin S expression. This hypothesis will be tested in Aim 3. The hypotheses and experiments presented here link together three molecules that have previously been associated independently with itch and inflammation: PARs, cathepsins and IL-31. PUBLIC HEALTH RELEVANCE: Itching is a major symptom of dermatologic and many internal conditions and is difficult to treat. The goal of this project is to examine how certain proteins, called cysteine proteases, not previously associated with itching, appear to turn on specific receptors and cause itching. The results of this project may lead to the development of new drugs to treat itch.